Ovarian Cancer News and reporting on ovarian cancer. PLOS Papers on Anticancer Drugs, SARS-CoV-2 Diversity in Hosts, Ovarian Cancer Blood Transcripts In PLOS this week: screen of genes influencing response to cancer drugs, diversity of SARS-CoV-2 in individual hosts, and more. Qiagen, OncXerna Therapeutics Ink Companion Dx Development, Technology-Licensing Deal The partners will develop an NGS companion diagnostic for navicixizumab, which OncXerna is developing as a treatment for patients with ovarian cancer. PLOS Papers on Ovarian Cancer MicroRNAs, Cerebral Ataxia in Dogs, Dengue Fever Markers In PLOS this week: blood serum microRNA may identify early-stage ovarian cancer, gene deletion tied inherited cerebellar ataxia in Belgian Shepherd dogs, and more. Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib The NGS firm will work with Impact to develop companion diagnostics to select patients eligible for Impact's synthetic lethality drugs, beginning with senaparib. PLOS Papers on Adverse Drug Reaction GWAS, Rare Variant Gene Regulators, Ovarian Cancer MicroRNAs In PLOS this week: genome-wide association study of adverse drug reactions, new approach to identify variants affecting gene expression regulation, and more. Feb 19, 2021 BRCA2 Variants of Unknown Significance Reclassified Through Functional Data Additions Feb 19, 2021 AmoyDx, AstraZeneca Strike Ovarian Cancer Companion Diagnostic Alliance Nov 23, 2020 Multigene Panel Germline Testing of Cancer Patients Detects Unexpected Pathogenic Variants Premium Nov 19, 2020 Aspira Collaborating With Baylor Genetics on Ovarian Cancer Early Detection Test Nov 18, 2020 MSK Study Suggests Germline Tests May Miss Mosaic Cancer Risk Mutations in Some Patients Premium Nov 16, 2020 InterVenn Biosciences Raises $34M in Series B Round to Commercialize Ovarian Cancer Test Nov 16, 2020 Myriad Genetics Expands MyChoice CDx Access Through Partnerships in Europe, China Oct 27, 2020 FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Three Targeted Therapies Oct 22, 2020 Ideaya Biosciences, Broad Institute Partner on Synthetic Lethality-Based Cancer Drug Discovery Oct 6, 2020 BostonGene Collaborates With Transgene, NEC Corporation on Trials of Bespoke Cancer Vaccine Sep 24, 2020 Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test Sep 16, 2020 Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable Premium Aug 20, 2020 Polygenic Variation Affects Disease Risk From Monogenic Variants, Study Finds Jul 27, 2020 Genetic Screening Identifies Many at Risk of Inherited Disease But Missed by Routine Care Jul 22, 2020 Devyser Gains CE Mark for NGS Hereditary Breast and Ovarian Cancer Test Jul 17, 2020 BRCA1/2 Population Screening Predicted to be Cost-Effective in Countries With Different Income Levels Jun 22, 2020 Single-Cell Analysis of Ovarian Cancer Points to Potential Treatment Avenue Jun 19, 2020 Incidental Findings Most Frequent in Cancer Risk Genes, EMERGE III Data Show Jun 4, 2020 Studies Show Potential of Video, Online Education to Expand Cancer Risk Genetic Test Access Premium May 29, 2020 Tumor Microbiome Appears to Vary With Cancer Type Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.